Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Lack of public trust led to cancellation of mRNA vaccine contracts
Health and Wellness

Lack of public trust led to cancellation of mRNA vaccine contracts

Last updated: August 11, 2025 10:15 am
Share
Lack of public trust led to cancellation of mRNA vaccine contracts
SHARE

The head of the National Institutes of Health, Jay Bhattacharya, recently offered a new explanation for the federal government’s decision to cancel $500 million in contracts aimed at developing messenger RNA (mRNA) vaccines. Bhattacharya stated during an appearance on right-wing provocateur Steve Bannon’s podcast that the platform is not viable due to a lack of public trust.

Bhattacharya’s rationale for the contract cancellations diverges from the reasoning provided by his boss, Health Secretary Robert F. Kennedy Jr., who cited concerns about the effectiveness and safety of vaccines developed using mRNA technology. Bhattacharya, who gained national prominence as a co-author of the Great Barrington Declaration advocating for the lifting of Covid containment measures, pointed to the declining uptake of Covid boosters as evidence that the public is hesitant to receive mRNA-based vaccines.

According to Bhattacharya, the public’s distrust of mRNA vaccines renders the platform ineffective for widespread vaccination efforts. Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy, criticized Bhattacharya’s comments as disingenuous. Osterholm highlighted the role of influential figures like Kennedy in perpetuating misinformation about vaccine safety and efficacy, contributing to public reluctance.

Bhattacharya confirmed that it was Kennedy’s decision to terminate the contracts issued by the Biomedical Advanced Research and Development Authority (BARDA), a division of the Department of Health and Human Services (HHS) responsible for developing medical countermeasures. In addition to the $500 million in canceled contracts, BARDA also rescinded $766 million in grants to Moderna for flu vaccine development.

While Bhattacharya acknowledged the promise of mRNA technology, he emphasized that the platform is not yet ready for prime time in the context of vaccines. He expressed concerns about the inability to quantify the antigen dose delivered by mRNA vaccines, as they rely on the body’s cells to produce the spike protein of the virus. Critics argue that this lack of quantifiability raises safety and efficacy issues.

See also  India's Public Broadcaster Unveils Waves Streaming Platform

Scott Hensley, a microbiology professor at the University of Pennsylvania, countered Bhattacharya’s concerns by highlighting similar challenges in live attenuated vaccines. Hensley noted that both mRNA and live attenuated vaccines have undergone rigorous clinical testing to demonstrate safety and efficacy. He emphasized that the inability to precisely measure antigen amounts is a known issue in vaccinology.

Bhattacharya also pointed out that mRNA Covid vaccines do not prevent infection, citing his own experience of contracting Covid after vaccination. This aligns with the nature of all Covid vaccines, which primarily aim to reduce the severity of illness rather than completely prevent infection. Overall, the debate surrounding mRNA vaccines underscores ongoing challenges in public health communication and vaccine development. The development of vaccines is crucial in combating the spread of infectious diseases, and various production platforms are used to create these life-saving treatments. While vaccines may not completely prevent infections, they do significantly lower the risk of severe illness that could result in hospitalization or death.

Dr. Hensley, a prominent figure in the field, emphasized the importance of vaccines in saving lives during a pandemic. He acknowledged that while the ideal scenario would be a vaccine that prevents infections altogether, the ability of vaccines to keep individuals out of the hospital is a significant achievement in itself.

The use of mRNA technology in vaccine production has shown promising results, leading to speculation about potential improvements in the future. Dr. Hensley believes that further investment in research and development of mRNA vaccines is essential for enhancing the efficacy of this production method. By continuing to invest in this platform, there is a possibility of developing vaccines that can elicit broader immune responses and provide better protection against infections, including mucosal responses.

See also  Study the US finds growing heart disease gap linked to wealth, education

Dr. Hensley’s advocacy for the advancement of mRNA technology underscores the need for ongoing research and innovation in vaccine development. By investing in this platform now, it is possible to be better prepared to respond to future pandemics and emerging infectious diseases. The potential for improved vaccines in the next 5-10 years highlights the importance of continuing to explore and enhance existing production methods.

In conclusion, vaccines play a crucial role in preventing the spread of infectious diseases and reducing the severity of illness in individuals. The evolution of production platforms, such as mRNA technology, holds promise for the development of more effective vaccines in the future. By investing in research and development now, we can ensure that we are better equipped to tackle the challenges of tomorrow’s health crises.

TAGGED:CancellationcontractsLackLedmRNAPublictrustvaccine
Share This Article
Twitter Email Copy Link Print
Previous Article Judge denies release of Ghislaine Maxwell grand jury transcripts : NPR Judge denies release of Ghislaine Maxwell grand jury transcripts : NPR
Next Article One Piece Season 2 Release Date, News, Cast and Trailer One Piece Season 2 Release Date, News, Cast and Trailer
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Republicans hope Trump can convince holdouts to support bill : NPR

President Trump spoke to House Republicans on Tuesday as they prepare to vote on a…

May 20, 2025

Cosmos Were Flowing (and So Were the Easter Eggs) at the And Just Like That Season 3 Bash

And Just Like That: A Glamorous Night of Nostalgia and ExcitementIndeed, nods to Ms. Bradshaw…

May 22, 2025

The Brief and Illustrious Life of the Telegraph

The optical telegraph, a precursor to the telephone, captivated the people of 19th-century France before…

June 25, 2025

The Best Dressed Stars of the Week Nailed Modern Glamour

This week at Paris Fashion Week, the spring 2026 shows showcased an array of glamour…

October 5, 2025

Trump Is Personally Threatening Republican Senators Who Oppose Matt Gaetz

Former President Donald Trump is reportedly using threats of primary challenges and the promise of…

November 22, 2024

You Might Also Like

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests
Health and Wellness

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

October 31, 2025
Trust Government Statistics, Not Government
Economy

Trust Government Statistics, Not Government

October 31, 2025
Once Again A Blood Pressure Medication Recall For Cancer Concerns
Health and Wellness

Once Again A Blood Pressure Medication Recall For Cancer Concerns

October 31, 2025
IVF research, FDA vouchers, dementia: Morning Rounds
Health and Wellness

IVF research, FDA vouchers, dementia: Morning Rounds

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?